# Athyrium Capital Management, LP

Investor in New York, New York

## About Athyrium Capital Management, LP

Athyrium is a specialized asset management company formed in 2008 to focus on investment opportunities in the broader healthcare and life sciences sectors encompassing biotechnology, pharmaceuticals, healthcare services, healthcare technology and medical devices and products.

Our Focus The Athyrium team has substantial investment experience in the healthcare sector across a wide range of asset classes, including public equity, private equity, fixed income, royalties and other structured securities.

Athyrium advises funds with over $4.6 billion of committed capital. We value our investors and are thankful for the trust they have placed in us.

▪ Up to $200 million per investment with ability to flex up opportunistically ▪ Public and private companies ▪ Commercial-stage companies with compelling products and differentiated services ▪ Industry-leading management teams ▪ Multi-year commitments with opportunity to upsize over time ▪ Global investment mandate

## People

- **Jeffrey Ferrell**, Managing Partner

## Key Facts

- **Location:** New York, New York
- **Investor Type:** Private Equity
- **Founded:** 2008

## Investment Industries

- Biotech
- Health and Wellness
- Medical/Healthcare

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/athyrium-capital-management-lp
- More investors: [Biotech Investors in New York](https://askforfunding.com/site/angel-investors/new-york/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.